Detalhe da pesquisa
1.
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Blood
; 131(8): 888-898, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233821
2.
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Transfusion
; 60(8): 1867-1872, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654201
3.
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.
Am J Hematol
; 95(2): 151-155, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31709579
4.
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
Acta Haematol
; 143(1): 40-50, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31315113
5.
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Cancer
; 125(9): 1507-1517, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694529
6.
Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients.
Blood
; 130(19): 2073-2083, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972015
7.
Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry.
Am J Hematol
; 94(6): 641-649, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30896890
8.
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
Br J Haematol
; 181(6): 760-769, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672827
9.
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project.
Haematologica
; 103(7): 1191-1197, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599200
10.
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.
Am J Hematol
; 93(11): 1318-1326, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094870
11.
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
Cancer
; 123(7): 1174-1183, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27911989
12.
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.
Blood
; 125(12): 1883-9, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25605368
13.
Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.
Haematologica
; 100(6): 794-800, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795722
14.
Peripheral T-cell lymphoma.
Blood
; 117(25): 6756-67, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21493798
15.
Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
J Am Acad Dermatol
; 69(4): 537-43, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23849563
16.
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma.
Blood Adv
; 7(5): 801-810, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342852
17.
Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations.
Blood Adv
; 7(3): 445-457, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947128
18.
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network.
Blood Adv
; 7(17): 5047-5054, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163360
19.
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
Clin Cancer Res
; 29(10): 1869-1878, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826995
20.
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
Hematol Oncol
; 35(4): 914-917, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402335